UTHR(United Therapeutics Corporation) · 财务报表

UTHR(United Therapeutics Corporation) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$1.69B$1.94B$2.33B$2.88B$3.18B
毛利润$1.56B$1.78B$2.07B$2.57B$2.80B
营业利润$555.90M$979.70M$1.18B$1.38B$1.49B
净利润$475.80M$727.30M$984.80M$1.20B$1.33B
经营现金流$598.20M$802.50M$978.00M$1.33B$1.56B
自由现金流$477.40M$663.70M$747.60M$1.08B$1.04B
摊薄每股收益$10.06$15.00$19.81$24.64$27.86

United Therapeutics Corporation UTHR